Clinical Trial

AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT

Study acronym: CONNECT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
National, retro- and prospective, observational, multicenter clinical research platform to connect clinical and genomic data of patients with advanced (locally advanced, inoperable, or metastatic) solid tumors (excluding NSCLC, SCLC, and mesothelioma) with results from multi-gene next-generation sequencing (NGS) panels (\>30 genes)
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-01-18; most recent amendment 2025-02-13.
Status change: Not Yet Recruiting → Recruiting 2023-02-16
Trial Details
NCT Number NCT05701150
Lead Sponsor AIO-Studien-gGmbH
Collaborators: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company, Merck Sharp & Dohme LLC, Janssen-Cilag G.m.b.H
Conditions Advanced Solid Tumor
Enrollment 3,000 participants
Start Date 2022-12-08
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-17